J. Wanders
- Oncology top 0.05%
- Cancer Treatment and Pharmacology 68
- Colorectal Cancer Treatments and Studies 29
- HER2/EGFR in Cancer Research 22
- Lung Cancer Research Studies 11
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 13
- Advanced Breast Cancer Therapies 11
- Hepatology top 0.5%
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 11
- Otorhinolaryngology top 0.5%
-
- Cancer therapeutics and mechanisms 34
- Co-authors
- Jaap VerweijElizabeth A. EisenhauerM. van GlabbekeMichaele C. ChristianPatrick TherasseSusan G. ArbuckRichard KaplanAllan T. van Oosterom
- Journals
- European Journal of Cancer (30 papers)Journal of Clinical Oncology (21 papers)Annals of Oncology (16 papers)
- Partner nations
- NetherlandsUnited KingdomBelgium
In The Last Decade
J. Wanders
131 papers receiving 19.1k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 11.1k
- Pulmonary and Respiratory Medicine 7.9k
- Hepatology 1.9k
- Cancer Research 2.8k
- Otorhinolaryngology 508
Countries citing papers authored by J. Wanders
This map shows the geographic impact of J. Wanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Wanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Wanders more than expected).
Fields of papers citing papers by J. Wanders
This network shows the impact of papers produced by J. Wanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Wanders. The network helps show where J. Wanders may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Wanders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 37 | |
| 2 | 2012 | 21 | |
| 3 | 2012 | 150 | |
| 4 | 2010 | 13 | |
| 5 | 2008 | 24 | |
| 6 | 2007 | 27 | |
| 7 | 2004 | 10 | |
| 8 | 2003 | 75 | |
| 9 | 2002 | 11 | |
| 10 | Combined results of 4 phase I and pharmacokinetic (PK) studies of E7070, a novel chloroindolyl-sulphonamide inhibiting the activation of cdk2 and cyclin E | 2000 | 7 |
| 11 | 2000 | 20 | |
| 12 | 2000 | 10 | |
| 13 | 1996 | 32 | |
| 14 | 1994 | 108 | |
| 15 | 1994 | 9 | |
| 16 | 1994 | 28 | |
| 17 | 1993 | 123 | |
| 18 | 1992 | 10 | |
| 19 | 1992 | 5 | |
| 20 | 1991 | 7 |
About J. Wanders
J. Wanders is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 132 papers that have together received 19.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (68 papers), Cancer therapeutics and mechanisms (34 papers), Colorectal Cancer Treatments and Studies (29 papers), HER2/EGFR in Cancer Research (22 papers), Lung Cancer Treatments and Mutations (13 papers), Advanced Breast Cancer Therapies (11 papers), Lung Cancer Research Studies (11 papers) and Breast Cancer Treatment Studies (11 papers). The work is most often cited by research in Oncology (11.1k citations), Pulmonary and Respiratory Medicine (7.9k citations) and Hepatology (1.9k citations). J. Wanders has collaborated with scholars based in Netherlands, United Kingdom and Belgium. Frequent co-authors include Jaap Verweij, Elizabeth A. Eisenhauer, M. van Glabbeke, Michaele C. Christian, Patrick Therasse, Susan G. Arbuck, Richard Kaplan, Allan T. van Oosterom, Larry Rubinstein and Patrick Schöffski. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.